| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
24,035 |
21,531 |
$4.13M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,309 |
2,808 |
$2.58M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
18,413 |
17,079 |
$2.14M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,384 |
4,562 |
$2.02M |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,854 |
3,663 |
$893K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
11,275 |
10,658 |
$635K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,490 |
2,101 |
$612K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,423 |
5,445 |
$606K |
| G0378 |
Hospital observation service, per hour |
937 |
748 |
$586K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,083 |
4,901 |
$476K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,178 |
2,602 |
$462K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,848 |
2,515 |
$448K |
| 80053 |
Comprehensive metabolic panel |
14,872 |
12,150 |
$420K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,718 |
4,688 |
$360K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,864 |
1,949 |
$350K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,641 |
12,075 |
$297K |
| 80050 |
General health panel |
3,066 |
2,789 |
$278K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
706 |
571 |
$277K |
| 87631 |
|
1,006 |
974 |
$270K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
98 |
97 |
$224K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,810 |
4,155 |
$224K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,045 |
1,307 |
$211K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
410 |
399 |
$202K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,042 |
1,988 |
$194K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,426 |
2,889 |
$182K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,203 |
838 |
$172K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
431 |
372 |
$169K |
| 83880 |
|
2,005 |
1,785 |
$157K |
| 83605 |
|
4,993 |
4,064 |
$153K |
| 71045 |
Radiologic examination, chest; single view |
5,084 |
3,976 |
$153K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,360 |
2,185 |
$144K |
| 59025 |
Fetal non-stress test |
895 |
426 |
$141K |
| 84484 |
|
4,871 |
3,193 |
$140K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,267 |
1,178 |
$131K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,137 |
1,090 |
$113K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,137 |
1,090 |
$111K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
292 |
240 |
$109K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
663 |
507 |
$104K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,714 |
704 |
$103K |
| 83690 |
|
5,190 |
4,613 |
$101K |
| 71046 |
Radiologic examination, chest; 2 views |
1,654 |
1,490 |
$95K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
816 |
357 |
$92K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
768 |
704 |
$91K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,073 |
1,952 |
$91K |
| 96376 |
|
2,327 |
1,716 |
$87K |
| 36415 |
Collection of venous blood by venipuncture |
12,118 |
9,630 |
$84K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,334 |
2,805 |
$78K |
| 81025 |
|
3,719 |
3,447 |
$78K |
| 87040 |
|
2,504 |
1,442 |
$72K |
| 82077 |
|
1,636 |
1,371 |
$71K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,412 |
1,304 |
$68K |
| 87088 |
|
2,879 |
2,712 |
$61K |
| 84145 |
|
977 |
870 |
$59K |
| 83735 |
|
3,501 |
2,950 |
$57K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,472 |
1,365 |
$56K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
429 |
408 |
$55K |
| 81003 |
|
7,484 |
6,682 |
$54K |
| 81001 |
|
6,041 |
4,966 |
$53K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,480 |
4,624 |
$53K |
| 87077 |
|
1,925 |
1,795 |
$52K |
| 85730 |
|
3,445 |
3,145 |
$51K |
| 93041 |
|
2,279 |
2,055 |
$50K |
| 82805 |
|
293 |
224 |
$46K |
| 85610 |
|
4,379 |
3,862 |
$46K |
| 76830 |
Ultrasound, transvaginal |
273 |
262 |
$45K |
| 76801 |
|
294 |
266 |
$45K |
| 94060 |
|
418 |
391 |
$45K |
| 82150 |
|
2,564 |
2,335 |
$44K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
61 |
61 |
$43K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,471 |
1,914 |
$42K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
64 |
54 |
$41K |
| 87186 |
|
1,643 |
1,525 |
$41K |
| 73610 |
|
381 |
336 |
$40K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,078 |
1,745 |
$39K |
| 73130 |
|
388 |
342 |
$38K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
315 |
312 |
$37K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
693 |
498 |
$34K |
| 85379 |
|
1,270 |
1,200 |
$34K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,265 |
1,213 |
$33K |
| 85027 |
|
2,056 |
1,766 |
$33K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,297 |
1,248 |
$33K |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
838 |
805 |
$31K |
| 97161 |
|
322 |
309 |
$30K |
| 87070 |
|
1,091 |
977 |
$29K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
387 |
293 |
$29K |
| 86140 |
|
2,088 |
1,898 |
$27K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,395 |
3,095 |
$26K |
| 84702 |
|
620 |
529 |
$26K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,148 |
1,777 |
$26K |
| 86850 |
|
630 |
361 |
$25K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
202 |
191 |
$25K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
299 |
293 |
$24K |
| 80061 |
Lipid panel |
624 |
603 |
$24K |
| 73110 |
|
200 |
159 |
$23K |
| J2704 |
Injection, propofol, 10 mg |
1,679 |
1,367 |
$23K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
925 |
808 |
$22K |
| 73562 |
|
217 |
201 |
$21K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
33 |
25 |
$20K |
| 94729 |
|
155 |
147 |
$19K |
| 90715 |
|
288 |
286 |
$19K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
138 |
114 |
$18K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
104 |
103 |
$18K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
934 |
766 |
$18K |
| 84703 |
|
729 |
676 |
$17K |
| 82248 |
|
1,223 |
1,057 |
$16K |
| 73030 |
|
178 |
151 |
$15K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
345 |
330 |
$13K |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
206 |
204 |
$13K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
637 |
364 |
$12K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,409 |
1,286 |
$12K |
| 70486 |
|
25 |
25 |
$11K |
| 73630 |
|
129 |
111 |
$10K |
| 93017 |
|
114 |
114 |
$10K |
| 82948 |
|
660 |
430 |
$10K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
13 |
13 |
$10K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
152 |
146 |
$10K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,309 |
1,211 |
$10K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
866 |
764 |
$9K |
| 82550 |
|
524 |
476 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
965 |
666 |
$7K |
| 87210 |
|
482 |
456 |
$7K |
| 86901 |
|
685 |
630 |
$7K |
| C9113 |
Injection, pantoprazole sodium, per vial |
676 |
589 |
$7K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
12 |
12 |
$7K |
| 86900 |
|
594 |
550 |
$6K |
| 76642 |
|
92 |
83 |
$6K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
361 |
274 |
$5K |
| 97035 |
|
273 |
124 |
$5K |
| 85651 |
|
552 |
524 |
$5K |
| 87205 |
|
437 |
371 |
$5K |
| 96367 |
|
58 |
54 |
$5K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
272 |
268 |
$5K |
| J7050 |
Infusion, normal saline solution, 250 cc |
290 |
216 |
$4K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
111 |
43 |
$4K |
| 87420 |
|
87 |
84 |
$4K |
| J2060 |
Injection, lorazepam, 2 mg |
387 |
338 |
$4K |
| 71250 |
|
17 |
12 |
$4K |
| 80305 |
|
122 |
111 |
$3K |
| 84439 |
|
148 |
142 |
$3K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
27 |
13 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
45 |
37 |
$3K |
| 85007 |
|
271 |
239 |
$2K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
83 |
66 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
118 |
118 |
$2K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
39 |
37 |
$2K |
| J3490 |
Unclassified drugs |
89 |
78 |
$2K |
| 73502 |
|
17 |
12 |
$2K |
| 80320 |
|
2,332 |
1,900 |
$2K |
| 94726 |
|
13 |
12 |
$2K |
| 80047 |
|
61 |
56 |
$2K |
| 97162 |
|
15 |
13 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15 |
13 |
$1K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
76 |
69 |
$1K |
| 82565 |
|
131 |
128 |
$1K |
| 87220 |
|
101 |
91 |
$1K |
| 73560 |
|
16 |
12 |
$1K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
154 |
127 |
$1K |
| 76000 |
|
12 |
12 |
$1K |
| 82570 |
|
69 |
66 |
$1K |
| 12001 |
|
12 |
12 |
$900.51 |
| 82140 |
|
20 |
15 |
$875.67 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
45 |
38 |
$787.83 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
189 |
178 |
$717.98 |
| 86703 |
|
13 |
12 |
$648.58 |
| 36600 |
|
15 |
14 |
$568.61 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
90 |
76 |
$555.24 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
640 |
617 |
$552.14 |
| 82247 |
|
36 |
12 |
$539.91 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
74 |
68 |
$523.03 |
| 85014 |
|
137 |
126 |
$517.41 |
| 87340 |
|
14 |
14 |
$516.24 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
32 |
24 |
$350.36 |
| 93016 |
|
32 |
30 |
$253.06 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
28 |
26 |
$239.72 |
| 82043 |
|
13 |
13 |
$224.16 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
13 |
12 |
$214.70 |
| 36416 |
|
31 |
29 |
$212.94 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
17 |
12 |
$210.49 |
| 93018 |
|
32 |
30 |
$150.92 |
| J2471 |
Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg |
29 |
26 |
$140.48 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
13 |
12 |
$139.93 |
| 84520 |
|
13 |
13 |
$136.18 |
| J1815 |
Injection, insulin, per 5 units |
14 |
12 |
$134.44 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
15 |
14 |
$129.91 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
13 |
13 |
$121.51 |
| A4215 |
Needle, sterile, any size, each |
497 |
483 |
$114.68 |
| 93000 |
|
18 |
17 |
$104.23 |
| 84100 |
|
13 |
12 |
$95.94 |
| 81015 |
|
71 |
68 |
$85.93 |
| 80329 |
|
1,596 |
858 |
$63.02 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
12 |
12 |
$31.86 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
30 |
26 |
$28.29 |
| 85008 |
|
28 |
25 |
$10.94 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
13 |
$5.64 |
| A9270 |
Non-covered item or service |
752 |
556 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
80 |
72 |
$0.00 |